Hepatitis E virus (HEV) causes acute hepatitis with approximately 20 million cases per year 14 globally. While HEV is endemic in certain regions of Asia, Africa and South America, it is 15 considered an emerging foodborne pathogen in developed countries. Based on genetic diversity, 16 HEV is classified into different genotypes, with genotype 3 (HEV-3) being most prevalent in 17 Europe and North America. The transmission of HEV-3 has been shown to be zoonotic and 18 mainly associated with the consumption of raw or undercooked pork products. Herein, we 19 investigated the efficacy of high-pressure processing (HPP) in the inactivation of HEV-3 using a 20 cell culture system. HPP has been indicated as a promising nonthermal pathogen inactivation 21 strategy for treatment of certain high-risk food commodities, without any noticeable changes in 22 their nature. For this purpose, we treated HEV-3 in media as well as in artificially inoculated 23 pork pâté, with different conditions of HPP: 400 MPa for 1 and 5 minutes, as well as 600 MPa 24 for 1 and 5 minutes, at ambient temperature. In general, we observed approximately a 2-log 25 reduction in HEV load by HPP treatments in media; however, similar treatment in the pork pâté 26 resulted in a much lower reduction in viral load. Therefore, the efficacy of HPP treatment in the 27 inactivation of HEV-3 is matrix-dependent.
Introduction 7 ˚C and the supernatant was discarded. The pellets containing the virus particles were suspended 126 in 500 µl PBS and stored at -80 ˚C until required for the infectivity assay.
127
Determining the Limit of Quantification 128 In order to determine the limit of quantification of the infectivity assay, cell culture-adapted 129 HEV-3 strain 47832c at ten concentrations from 5×10 2 to 1×10 6 genome copies per well were 130 used to infect A549/D3 cells in triplicate experiments (29, 30) . The infected and control cells, 131 which were not exposed to viral particles, were cultured for 14 days. The media supernatant was 132 then collected and the HEV RNA levels were analysed by droplet-digital RT-PCR (ddRT-PCR).
133

RNA Isolation and Quantification
134
The Viral RNA Mini Kit (Qiagen, Mississauga, Ontario, Canada) was used to extract RNA from 135 the collected infectivity assay growth media. Quantification of recovered RNA was conducted as 136 previously described using Bio-Rad droplet digital PCR (ddRT-PCR) technology (25, 32) .
137
DNA sequencing 138 Conventional RT-PCR was carried out using the HEV-11 primers (33), which amplifies the 139 region between the positions 5468-6018 of the HEV-3 strain 47832c. Gel-purified RT-PCR 140 products were sequenced directly using the BigDye ® terminator v 3. 
Results
154
Limit of Quantification
155
The correlation between the inoculated HEV genome copy number and the harvested genome 156 copy number at 14 days post infection (d.p.i) is shown in Figure 1 . The relationship between the 157 two is linear over the range studied with a r 2 value of 0.9823, this demonstrates that the amount 158 of harvested HEV RNA is directly correlated to the of HEV inoculum. The limit of 159 quantification by this method was determined to be 1×10 4 genome copies per well (100 gc/µl) of 160 the inoculated virus, and inoculation with titres below this amount did not reliably and 161 reproducibly produce quantifiable progeny virus at 14 d.p.i. Importantly, these data suggest that 162 on average, 1 in 10.2 ± 4.8 of the inoculated genomes is capable of replication in cell culture. In 163 other words, the infectivity ratio of the virus is 1 in 10.2± 4.8 genome.
164
HEV inactivation in cell culture media 165 In commercial food processing, HPP is applied to meat products with pressures typically ranging 166 between 400 and 600 MPa for 1 to 10 min (37). To determine the role of pressure and hold time 167 on the inactivation of HEV by HPP, HEV-3 strain 47832c, in cell culture media, were treated at 168 pressure levels of 400 MPa and 600 MPa for 1min and 5 min starting at 24 °C. The undiluted 169 9 and 1:10 diluted HPP-treated viral solutions, along with untreated controls, were used to infect 170 A549/D3 cells in duplicate as described above. The decrease in infectious HEV particles was 171 determined by comparing the reduction in HEV RNA at 14 d.p.i in HPP-treated samples with the 172 untreated controls. As shown in Figure 2 , reductions of 1.6±0.33 log and 1.93±0.29 log in 173 infectious viral particles were observed for the samples that were treated at 400 MPa for 1 min 174 and 5 min, respectively. Increasing the pressure to 600 MPa resulted in a slight but not 175 statistically significant increase in viral inactivation; 2.27±0.03 log and 2.2±0.28 log reduction 176 for 1 min and 5 min treatments, respectively ( Figure 2 ). Neither varying the treatment pressure 177 (400 MPa or 600 MPa) nor the hold time at maximum pressure (1 min or 5 min) resulted in 178 statistically significant reductions in the viral inactivation (P > 0.1).
179
Examining amino acid variation in the capsid protein 180 The HEV capsid protein consists of 660 residues and 4 main structural and functional domains; 
208
We next employed this system to investigate HEV inactivation by HPP treatment. The untreated 209 and treated virus stocks were used to infect the A549 cells and the infected cells were examined 210 for the production of progeny virus in the culture. Using this system, we demonstrated that an 211 approximately 2-log reduction in viral load can be accomplished by treatment of HEV in media 212 at 400 MPa with a 1 min hold time. Increasing the pressure to 600 MPa or the hold time to 5 min 213 did not have any significant effect on the reduction of viral load. However, HEV in artificially 214 contaminated pâté was protected from HPP treatment, as the reduction in infectious HEV 215 particles was less than 0.5 log.
216
To the best of our knowledge, this is the first published study to quantify the inactivation of HEV The sequence analysis of partial capsid protein revealed that there is no amino acid change 237 between the treated and untreated viruses within the N and S domain. However, to determine 238 whether the capsid of the surviving viruses are different from the untreated viruses, full capsid 239 sequence analysis is required. In this study, our attempts to retrieve the full capsid sequence from 240 the treated samples were not successful. Nevertheless, we cannot rule out the possibility of 241 reversion of mutations during the culture period (14 d).
242
In this study, we observed that HEV in pork pâté was protected from HPP treatment, compared foods, a human volunteer study with oysters inoculated with 4 log PFU of norovirus (GI.1.
251
Norwalk) found that a treatment of 400 MPa (5 min hold, 6 °C) was insufficient to protect 252 volunteers, though 600 MPa was protective for all volunteers (51).
253
The protective effect of food components against viral capsid denaturation has already been 254 demonstrated (50). It has also been reported that fat increases the stability of hepatitis A virus in 255 skim milk and cream against heat treatment (52); however, whether the fat and salt content of the 256 treated matrix affects the structural integrity of HEV and its sensitivity towards pressure, needs 257 to be further investigated.
13
Our data demonstrated that the viral titre post HPP treatment of pâté under 600MPa for 5 min 259 reaches to 1.5×10 3 in cell culture. This indicates that replication of virus occurred, and therefore 260 the elimination of HEV infectivity was not complete. In another study, it was shown that the 261 treatment of HEV solution at 500 MPa for 15 min did not result in complete inactivation assayed 262 by using viability markers (PMAxx and platinum chloride, PtCl4-RT-qPCR) (43) . Knowing that 263 the virus is capable of replication (and therefore has the potential to cause illness) is important 264 for interpretation of surveillance and inactivation studies on HEV to inform risk assessment and 265 mitigation (28) . Especially that the dose-response relationship of HEV is unknown, and it is not 266 clear which level of infectivity reduction is required to prevent infection in human. Therefore, 267 the generation of more detailed data on the infectivity reduction for different HEV strain-matrix 268 combinations would enhance our understanding of HEV stability in the environment and in 269 foods. (29).
270
In summary, we have demonstrated that 1) there is a direct and linear correlation between the 271 viral titres used to infect A549/D3 cells and the harvested virus at 14 d.p.i 2) the effect of HPP 272 on inactivation of HEV depends on the surrounding matrix.
273
Acknowledgements 274 We would like to thank Dr. Reimar Johne from German Federal Institute for Risk Assessment, 
